Tatva Chintan Pharma Chem Limited (TATVA) — Financial Flexibility Index

Latest as of September 2023: 0.12x

Tatva Chintan Pharma Chem Limited (TATVA) has a Financial Flexibility Index of 0.12x as of September 2023. Free cash flow of Rs135.54 Million (operating CF Rs135.54 Million minus capex Rs0.00) represents 0% of total liabilities (Rs1.13 Billion). Also explore how fast is Tatva Chintan Pharma Chem Limited growing its equity to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.12x
Free Cash Flow / Total Liabilities

Free Cash Flow

Rs135.54 Million
Operating CF − Capex

Total Liabilities

Rs1.13 Billion
INR

Capital Expenditures

Rs0.00
INR

Tatva Chintan Pharma Chem Limited Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for Tatva Chintan Pharma Chem Limited across 8 annual periods. Check how strategically is Tatva Chintan Pharma Chem Limited's equity deployed to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Tatva Chintan Pharma Chem Limited (2018–2025)

Year-by-year free cash flow to debt coverage for Tatva Chintan Pharma Chem Limited. For the full company profile including market capitalisation, see Tatva Chintan Pharma Chem Limited (TATVA) total market value.

Year Flexibility Index Free Cash Flow (INR) Operating CF Total Liabilities YoY Change
2025 1.04x Rs1.01 Billion Rs246.71 Million Rs974.25 Million ▼ -62.7%
2024 2.78x Rs2.27 Billion Rs980.44 Million Rs816.36 Million ▲ +190.3%
2023 0.96x Rs2.31 Billion Rs277.83 Million Rs2.42 Billion ▲ +61.7%
2022 0.59x Rs1.10 Billion Rs203.78 Million Rs1.85 Billion ▲ +94.4%
2021 0.30x Rs452.89 Million Rs243.19 Million Rs1.49 Billion ▼ -45.7%
2020 0.56x Rs734.84 Million Rs253.12 Million Rs1.31 Billion ▲ +252.1%
2019 0.16x Rs171.42 Million Rs73.56 Million Rs1.08 Billion ▼ -66.8%
2018 0.48x Rs408.73 Million Rs104.12 Million Rs852.48 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities